Javascript must be enabled to continue!
Subendocardial Involvement as an Underrecognized LGE Subtype Related to Adverse Outcomes in Hypertrophic Cardiomyopathy
View through CrossRef
In a retrospective cohort study, 497 consecutive HCM patients with LGE confirmed by cardiac MR were collected. The risk of cardiovascular events increases with per percentage increase in LGE extent in HCM patients with extensive LGE (>15%). While instead of LGE extent, the subendocardium-involved LGE pattern, an underrecognized phenotype in HCM, is related to the adverse outcomes in patients with non-extensive LGE (<15%), especially for heart failure-related outcomes. RVIP LGE is commonly seen in HCM, but this LGE location does not merit a prognostic value.
Title: Subendocardial Involvement as an Underrecognized LGE Subtype Related to Adverse Outcomes in Hypertrophic Cardiomyopathy
Description:
In a retrospective cohort study, 497 consecutive HCM patients with LGE confirmed by cardiac MR were collected.
The risk of cardiovascular events increases with per percentage increase in LGE extent in HCM patients with extensive LGE (>15%).
While instead of LGE extent, the subendocardium-involved LGE pattern, an underrecognized phenotype in HCM, is related to the adverse outcomes in patients with non-extensive LGE (<15%), especially for heart failure-related outcomes.
RVIP LGE is commonly seen in HCM, but this LGE location does not merit a prognostic value.
Related Results
Prognostic impact of the concept of late gadolinium enhancement granularity in non-ischaemic dilated cardiomyopathy
Prognostic impact of the concept of late gadolinium enhancement granularity in non-ischaemic dilated cardiomyopathy
Abstract
Background
The prognostic stratification of non-ischaemic dilated cardiomyopathy (DCM) to predict the risk of death is ...
Late gadolinium enhancement patterns in severe symptomatic high-gradient aortic stenosis
Late gadolinium enhancement patterns in severe symptomatic high-gradient aortic stenosis
Abstract
Background
Left ventricular (LV) remodeling in patients with severe aortic valve stenosis (AS) is a complex process tha...
Improving prognostic accuracy in ischemic cardiomyopathy: the CMR-LGE score
Improving prognostic accuracy in ischemic cardiomyopathy: the CMR-LGE score
Abstract
Background
There is a need for accurate prognostic stratification tools in patients with ischemic cardiomyopathy (ICM)....
Comparative Analysis of the Coronary Arteries Flow Pattern in Secondary Myocardial Hypertrophies and by Sarcomeric Mutation
Comparative Analysis of the Coronary Arteries Flow Pattern in Secondary Myocardial Hypertrophies and by Sarcomeric Mutation
Background: Coronary flow with a diastolic predominance increases two to five times in hyperemia, mediated by vasodilation (coronary flow reserve, CFR) and, in hypertrophy, relativ...
GW24-e0343 CMR findings in patients with hypertrophic cardiomyopathy and negative T waves
GW24-e0343 CMR findings in patients with hypertrophic cardiomyopathy and negative T waves
Objectives
We sought to compare the clinical, morphologic and functional characteristics by late gadolinium-enhancement (LGE) cardiovascular magnetic resonance (C...
Comparison of Stress-rest and Stress-LGE analysis strategy in patients undergoing stress perfusion cardiovascular magnetic resonance
Comparison of Stress-rest and Stress-LGE analysis strategy in patients undergoing stress perfusion cardiovascular magnetic resonance
ABSTRACTBACKGROUNDStress perfusion cardiovascular magnetic resonance (CMR) is increasingly used without rest perfusion for the quantification of ischemia burden. However, the optim...
Whole‐Heart High‐Resolution Late Gadolinium Enhancement: Techniques and Clinical Applications
Whole‐Heart High‐Resolution Late Gadolinium Enhancement: Techniques and Clinical Applications
In cardiovascular magnetic resonance, late gadolinium enhancement (LGE) has become the cornerstone of myocardial tissue characterization. It is widely used in clinical routine to d...
Differentiation of Cardiac Amyloidosis and Hypertrophic Cardiomyopathy
Differentiation of Cardiac Amyloidosis and Hypertrophic Cardiomyopathy
ABSTRACT. Eriksson P, Backman C, Eriksson A, Eriksson S, Karp K, Olofsson B‐O (Departments of Internal Medicine, Geriatric Medicine, and Clinical Physiology, University Hospital, ...

